Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019
October 24, 2019 at 07:14 am EDT
Share
Guanhao Biotech Co.,Ltd. announced earnings results for the nine months ended September 30, 2019. For the nine months, the company announced sales was CNY 318.222 million compared to CNY 306.523 million a year ago. Operating income was CNY 13.032 million compared to CNY 21.524 million a year ago. Net income was CNY 14.039 million compared to CNY 25.267 million a year ago. Basic earnings per share from continuing operations was CNY 0.05 compared to CNY 0.1 a year ago.
Guanhao Biotech Co., Ltd. is a China-based company principally engaged in the research, development, production and distribution of regeneration medical materials and medical implanted devices. The Company primarily provides biological dura mater patches, chest general surgery department patching membranes (type P) and (type B), asepsis biological wound-surface protection membranes, type B dura matrix, intraocular lens as well as agent products. The Company is also engaged in provision of related technological services.
GUANHAO BIOTECH CO.,LTD. 
